Annals of Internal Medicine
https://pubmed.ncbi.nlm.nih.gov/?myncbishare=dukemlib&dr=abstract&otool=dukemlib&term=33560862
The evidence seems to support a net benefit for rRemdesivir in patients with moderate Covid 19, with a 5 day treatment period as effective as 10 days.